The sector’s latest impact report shows that demand for capital is continuing to outstrip supply. NBR talks to Kwetta, Nilo and Shower Canary on their fundraising efforts.
Shareholder update blames capital raising difficulties on tariffs and changes to superannuation rules.
Wellington-based startup is doing human trials on its patented peptide it hopes will disrupt the global beauty industry.
Jun Chu took part in the listed medicinal cannabis company’s $2.3m capital raise in late 2025.
It has also signed an agreement to commercialise a new technology that allows storage of injectables at room temperature.
The startup that was trying to design plants to manufacture life-saving medicines has pulled the plug.
The Series A investment will help commercialise the medical device company’s portable photon-counting CT scanners in the US and NZ.
Hale Animal Health has added Australia animal health investor Arrow Ventures onto its cap table.
The money will go towards a pilot plant to scale its pioneering sustainable Celluspheres technology.
The startup is close to securing a strategic US investor that would allow the co-founders to sidestep local VC seed money.